Streetbeat News

Analyst Ratings

THRX

HC Wainwright & Co. analyst Andrew Fein reiterated a Buy rating on Theseus Pharmaceuticals (NASDAQ:THRX) and maintained a $22 price target.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:20 am

ALLO

EF Hutton analyst Tony Butler reiterates a Buy rating on Allogene Therapeutics (NASDAQ:ALLO) and maintains a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 10:17 am

BURL

Bernstein analyst Aneesha Sherman maintains an Outperform rating on Burlington Stores (NYSE:BURL) but lowers the price target from $230 to $200.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:16 am

MDT

Bernstein analyst Lee Hambright maintains an Outperform rating on Medtronic (NYSE:MDT) but lowers the price target from $100 to $99.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:15 am

SPPI

HC Wainwright & Co. analyst Edward White reiterates a Neutral rating on Spectrum Pharma (NASDAQ:SPPI).

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:15 am

WDAY

JMP Securities analyst Patrick Walravens maintains a Market Outperform rating on Workday (NASDAQ:WDAY) and raises the price target from $210 to $252.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:14 am

IVA

HC Wainwright & Co. analyst Ed Arce reiterated a Buy rating on Inventiva (NASDAQ:IVA) and maintained a $35 price target.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 10:12 am

CGEM

HC Wainwright & Co. analyst Edward White reiterates a Buy rating on Cullinan Oncology (NASDAQ:CGEM) and maintains a $49 price target.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:12 am

GRCL

HC Wainwright & Co. analyst Emily Bodnar reiterates a Buy rating on Gracell Biotechnologies (NASDAQ:GRCL) and maintains a $12 price target.

Portfolio Pulse from richadhand@benzinga.com

May 26, 2023 | 10:10 am

BOLT

HC Wainwright & Co. analyst Edward White reiterates a Buy rating on Bolt Biotherapeutics (NASDAQ:BOLT) and maintains an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 10:08 am